Deoxycholic acid - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for deoxycholic acid and what is the scope of patent protection?
Deoxycholic acid
is the generic ingredient in two branded drugs marketed by Wilshire Pharms Inc and Abbvie, and is included in two NDAs. There are fifteen patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.Deoxycholic acid has one hundred and forty-one patent family members in thirty-seven countries.
There are thirty-three drug master file entries for deoxycholic acid. One supplier is listed for this compound.
Summary for deoxycholic acid
International Patents: | 141 |
US Patents: | 15 |
Tradenames: | 2 |
Applicants: | 2 |
NDAs: | 2 |
Drug Master File Entries: | 33 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 98 |
Clinical Trials: | 20 |
Patent Applications: | 6,163 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for deoxycholic acid |
What excipients (inactive ingredients) are in deoxycholic acid? | deoxycholic acid excipients list |
DailyMed Link: | deoxycholic acid at DailyMed |
Recent Clinical Trials for deoxycholic acid
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Massachusetts General Hospital | Phase 1 |
Johns Hopkins University | Phase 1 |
Juva Skin & Laser Center | Phase 4 |
Pharmacology for deoxycholic acid
Drug Class | Cytolytic Agent |
Physiological Effect | Decreased Cell Membrane Integrity |
Medical Subject Heading (MeSH) Categories for deoxycholic acid
Anatomical Therapeutic Chemical (ATC) Classes for deoxycholic acid
Paragraph IV (Patent) Challenges for DEOXYCHOLIC ACID
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
KYBELLA | Injection | deoxycholic acid | 10 mg/mL (2 mL) | 206333 | 1 | 2018-07-13 |
US Patents and Regulatory Information for deoxycholic acid
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abbvie | KYBELLA | deoxycholic acid | SOLUTION;SUBCUTANEOUS | 206333-001 | Apr 29, 2015 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||
Abbvie | KYBELLA | deoxycholic acid | SOLUTION;SUBCUTANEOUS | 206333-001 | Apr 29, 2015 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||
Abbvie | KYBELLA | deoxycholic acid | SOLUTION;SUBCUTANEOUS | 206333-001 | Apr 29, 2015 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||
Abbvie | KYBELLA | deoxycholic acid | SOLUTION;SUBCUTANEOUS | 206333-001 | Apr 29, 2015 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||
Wilshire Pharms Inc | DEOXYCHOLIC ACID | deoxycholic acid | SOLUTION;SUBCUTANEOUS | 212296-001 | Apr 2, 2021 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for deoxycholic acid
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Eurasian Patent Organization | 020806 | СПОСОБ ПОЛУЧЕНИЯ ДЕЗОКСИХОЛЕВОЙ КИСЛОТЫ (ВАРИАНТЫ), ДЕЗОКСИХОЛЕВАЯ КИСЛОТА, ПОЛУЧЕННАЯ УКАЗАННЫМ СПОСОБОМ, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, ЕЕ СОДЕРЖАЩАЯ, СПОСОБ УДАЛЕНИЯ ЖИРОВЫХ ОТЛОЖЕНИЙ (METHOD FOR PRERARING DEOXYCHOLIC ACID (EMBODIMENTS), DEOXYCHOLIC ACID PREPARED BY SAID METHOD, PHARMACEUTICAL COMPOSITION CONTAINING SAME, METHOD FOR REMOVAL OF FAT DEPOSITS) | ⤷ Sign Up |
Mexico | PA06013437 | USO DE UN DETERGENTE PARA LA ELIMINACION NO QUIRURGICA DE GRASA. (USE OF A DETERGENT FOR THE NON-SURGICAL REMOVAL OF FAT.) | ⤷ Sign Up |
Israel | 202203 | תכשיר חומצת מרה מלאכותי ושיטה להכנת החומצה (Synthetic bile acid composition and method for preparation of the bile acid) | ⤷ Sign Up |
European Patent Office | 2550968 | Utilisation d’un sel biliaire avec un agent analgésique ou anti-inflammatoire pour l'élimination non chirurgicale de graisse (Non-surgical removal of localized fat accumulation with a bile salt in conjunction with an analgesic or anti-inflammatory agent) | ⤷ Sign Up |
Japan | 2007538104 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for deoxycholic acid
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1758590 | CR 2017 00067 | Denmark | ⤷ Sign Up | PRODUCT NAME: DEOXYCHOLSYRE NATRIUMSALT; NAT. REG. NO/DATE: 59040 (DK) 20170703; FIRST REG. NO/DATE: IS IS/1/16/071/01 20160729 |
2380576 | 2020/043 | Ireland | ⤷ Sign Up | PRODUCT NAME: DEOXYCHOLIC ACID SODIUM SALT; NAT REGISTRATION NO/DATE: PA2103/003/001 20170602; FIRST REGISTRATION NO/DATE: SE/H/1547/001/DC 20160729 |
1758590 | PA2017006 | Lithuania | ⤷ Sign Up | PRODUCT NAME: DEZOKSICHOLIO RUGSTIES NATRIO DRUSKA; REGISTRATION NO/DATE: LT/1/16/3960/001 20160909 |
3692995 | 301229 | Netherlands | ⤷ Sign Up | PRODUCT NAME: DEOXYCHOLAAT; NATIONAL REGISTRATION NO/DATE: RVG120593 20170804; FIRST REGISTRATION: IS IS/1/16/071/01 20160729 |
1758590 | 132017000066197 | Italy | ⤷ Sign Up | PRODUCT NAME: SALE SODICO DI ACIDO DESOSSICOLICO(BELKYRA); AUTHORISATION NUMBER(S) AND DATE(S): 044896013, 20161219;IS/1/16/071/01, 20160729 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.